Stock Market News

TD downgrades Milestone Pharmaceuticals, suspends target on Etripamil uncertainty

Apr 1, 2025 - 20:32
 0
TD downgrades Milestone Pharmaceuticals, suspends target on Etripamil uncertainty
Read More

Tags:

Previous Article

Impax Core Bond Fund Q4 2024 Commentary

Next Article

Ardagh Metal Packaging's 'B-' rating under review by Fitch

Related Posts

U.S. paper industry urges Trump to negotiate deforestation-free status with EU

U.S. paper industry urges Trump to negotiate deforestat...

Feb 18, 2025  0

Steel stocks rise after Trump touts tariff policy benefits

Steel stocks rise after Trump touts tariff policy benefits

Feb 13, 2025  0

Michael Kors owner Capri's CFO Edwards to join Macy's as finance head

Michael Kors owner Capri's CFO Edwards to join Macy's a...

Apr 1, 2025  0